Thromboelastography as a Predictor of Mortality in Severe COVID-۱۹

  • سال انتشار: 1403
  • محل انتشار: مجله علوم دارویی و شیمی، دوره: 7، شماره: 9
  • کد COI اختصاصی: JR_JMCH-7-9_007
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 135
دانلود فایل این مقاله

نویسندگان

Usi Sukorini

Departement of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Sagita Adventia

Clinical Pathology Specialist Programme, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Agusta Paramita Adipradipta

Clinical Pathology Specialist Programme, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Annisa Ginar Indrarsi

Clinical Pathology Specialist Programme, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Ika Ridlawati

Clinical Pathology Specialist Programme, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Adika Zhulhi Arjana

Department of Clinical Pathology, Faculty of Medicine, Universitas Negeri Yogyakarta, Yogyakarta, Indonesia

Angeline Datu Intan Purnamasari

Clinical Pathology Specialist Programme, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Ika Trisnawati

Division of Pulmonology, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Akhmad Yun Jufan

Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

Nur Rahmi Ananda

Division of Pulmonology, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia

چکیده

Coronavirus disease ۲۰۱۹ (COVID-۱۹) was examined to cause abnormalities within the hemostatic system. Viscoelastic tests, such as thromboelastography (TEG), were employed to evaluate the function of specific components involved in the hemostatic process. This allowed for the identification of coagulopathy, which has the potential to serve as a predictor of mortality in COVID-۱۹ patients. This research aims to evaluate TEG as a predictor of ۳۰-day mortality in patients with severe COVID-۱۹. This study was a prospective observational cohort study conducted from April ۲۰۲۱ through November ۲۰۲۱. TEG and routine coagulation tests were performed during the first ۲۴ h when COVID-۱۹ patients were admitted into the intensive care unit. Coagulation status was determined by using TEG and analysed based on ۳۰-day mortality. Out of the ۷۵ patients evaluated with TEG, ۳۳ died within ۳۰ days (۴۴%), ۲۳ patients exhibited hyper-coagulation (۳۰.۷%), ۵ patients had hypocoagulation (۶.۷%), and ۴۷ patients showed normal coagulation (۶۲.۷%). Kaplan–Meier analysis revealed that the risk of mortality within ۳۰ days was higher in hyper-coagulation and hypocoagulation compared to the normal coagulation groups. In the hypocoagulation group, the hazard ratio was ۳.۲۷ (۹۵% CI ۱.۱۴۱–۹.۳۷۲; p = ۰.۰۲۷), while in the hyper-coagulation group, it was ۱.۶۴ (۹۵% CI ۰.۷۹۴–۳.۳۷۹; p = ۰.۱۸۱). Using the TEG as a tool for examination to assess the coagulation status to predict mortality in severe COVID-۱۹ cases, the research finds out that the group of patients exhibiting hypocoagulation was at a ۳.۲۷-fold high risk of mortality within ۳۰ days in comparison with the group showing normal coagulation.

کلیدواژه ها

THROMBOELASTOGRAPHY, COVID-۱۹, Coagulopathy, mortality, predictor

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.